Literature DB >> 15192248

Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition.

Andrew J Coull1, Peter M Rothwell.   

Abstract

BACKGROUND: There is considerable variation in the definitions used for recurrent stroke. Most epidemiological studies exclude events within the first 28 days (eg, Monitoring Trends and Determinants in Cardiovascular Disease [MONICA]) or events within 21 days in the same territory as the presenting event (eg, most stroke incidence studies). However, recurrence is most common during this early period and these restrictive definitions could underestimate the benefits of early prevention.
METHODS: We determined the 90-day risk of recurrence after incident ischemic stroke in 2 population-based cohorts (Oxford Vascular Study [OXVASC] and Oxfordshire Community Stroke Project [OCSP]) with the 3 most common definitions: any stroke > or =24 hours after the incident event excluding early deterioration not caused by a stroke (definition A); as above, but excluding any stroke within 21 days in the same territory as the incident event (definition B); and any stroke > or =28 days after the incident event (definition C).
RESULTS: 657 patients had 93 recurrent strokes between 24 hours and 90 days after the incident event. The 90-day recurrence risks (95% CI) using definition A were 14.5% (11.5 to 17.5) in the OCSP and 18.3% (10.8 to 25.8) in the OXVASC. The equivalent risks using definitions B and C were 8.3% (5.9 to 10.8) and 4.8% (2.8 to 6.7), respectively, in the OCSP and 7.0% (1.6 to 12.4) and 5.9% (1.0 to 10.9) in the OXVASC. The definition A risk of recurrence was particularly high after partial anterior (22.9%,17.5 to 28.2) and posterior (19.5%,13.0 to 25.9) circulation strokes.
CONCLUSIONS: The 3 most widely used definitions of recurrent stroke yield markedly different 90-day risks. We suggest that, where possible, definition A be adopted as the standard to avoid underestimation of risk and to allow valid comparison of different studies.

Entities:  

Mesh:

Year:  2004        PMID: 15192248     DOI: 10.1161/01.STR.0000133129.58126.67

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  40 in total

1.  Transient ischaemic attacks: time to wake up.

Authors:  Peter M Rothwell
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

2.  Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction.

Authors:  Calin I Prodan; Julie A Stoner; Linda D Cowan; George L Dale
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-14       Impact factor: 6.200

3.  Does race predict stroke readmission? An analysis using the truncated negative binomial model.

Authors:  Byron S Kennedy
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

4.  A Bayesian joint model of recurrent events and a terminal event.

Authors:  Zheng Li; Vernon M Chinchilli; Ming Wang
Journal:  Biom J       Date:  2018-11-26       Impact factor: 2.207

5.  A score to predict early risk of recurrence after ischemic stroke.

Authors:  H Ay; L Gungor; E M Arsava; J Rosand; M Vangel; T Benner; L H Schwamm; K L Furie; W J Koroshetz; A G Sorensen
Journal:  Neurology       Date:  2009-12-16       Impact factor: 9.910

6.  Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study.

Authors:  Patrick F Chinnery; Hannah R Elliott; Anila Syed; Peter M Rothwell
Journal:  Lancet Neurol       Date:  2010-03-31       Impact factor: 44.182

7.  Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland.

Authors:  James Lewsey; Pardeep S Jhund; Michelle Gillies; Jim W T Chalmers; Adam Redpath; Andrew Briggs; Matthew Walters; Peter Langhorne; Simon Capewell; John J V McMurray; Kate MacIntyre
Journal:  BMC Med       Date:  2010-04-09       Impact factor: 8.775

8.  Improving adherence to medication in stroke survivors (IAMSS): a randomised controlled trial: study protocol.

Authors:  Ronan O'Carroll; Martin Dennis; Marie Johnston; Cathie Sudlow
Journal:  BMC Neurol       Date:  2010-02-24       Impact factor: 2.474

9.  Apollo stent for symptomatic atherosclerotic intracranial stenosis: study results.

Authors:  W-J Jiang; X-T Xu; M Jin; B Du; K-H Dong; J-P Dai
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

10.  Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry.

Authors:  Mark J Alberts; Deepak L Bhatt; Jean-Louis Mas; E Magnus Ohman; Alan T Hirsch; Joachim Röther; Geneviève Salette; Shinya Goto; Sidney C Smith; Chiau-Suong Liau; Peter W F Wilson; Ph Gabriel Steg
Journal:  Eur Heart J       Date:  2009-08-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.